We are live on
!
Find out more
GCM
Glenview Capital Management Portfolio holdings
AUM
$5.49B
1-Year Est. Return
46.89%
This Fund
S&P 500
This Quarter
Est. Return
+30.41%
1 Year Est. Return
+46.89%
3 Year Est. Return
+94.27%
5 Year Est. Return
+129.04%
10 Year Est. Return
+529.98%
AUM
$5.49B
AUM Growth
+$1.51B
(+38%)
Cap. Flow
+$309M
Cap. Flow
% of AUM
5.62%
Top 10 Holdings %
Top 10 Hldgs %
60.68%
Holding
58
New
14
Increased
15
Reduced
15
Closed
13
Avg Time Held Equity + Options
6.8
quarters
Top 10 Avg Time Held Equity + Options
6.3
quarters
Top 20 Avg Time Held Equity + Options
5
quarters
Avg Time Held Equity only
7.3
quarters
Top 10 Avg Time Held Equity only
7.1
quarters
Top 20 Avg Time Held Equity only
5.3
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Agilent Technologies
A
|
+$240M |
| 2 |
Thermo Fisher Scientific
TMO
|
+$181M |
| 3 |
Danaher
DHR
|
+$180M |
| 4 |
Global Payments
GPN
|
+$175M |
| 5 |
Meta Platforms (Facebook)
META
|
+$143M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$301M |
| 2 |
Advanced Micro Devices
AMD
|
+$144M |
| 3 |
DXC Technology
DXC
|
+$112M |
| 4 |
ZoomInfo Technologies
GTM
|
+$95.1M |
| 5 |
Centene
CNC
|
+$71M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 49.86% |
| 2 | Industrials | 12.99% |
| 3 | Technology | 12.58% |
| 4 | Consumer Discretionary | 9.03% |
| 5 | Miscellaneous | 8.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
Global Payments
GPN
$21.7B
| $646M | 11.77% |
8,906,709
+2,546,317
| +40% | +$175M |
2020 Q4
22 quarters
|
|
|
2
CVS Health
CVS
$112B
| $499M | 9.09% |
4,824,799
-3,372,000
| -41% | -$301M |
2023 Q4
10 quarters
|
|
3
Tenet Healthcare
THC
$21.5B
| $418M | 7.62% |
2,235,666
+710,812
| +47% | +$131M |
2013 Q2
52 quarters
|
|
|
4
Thermo Fisher Scientific
TMO
$244B
| $314M | 5.73% |
627,240
+376,715
| +150% | +$181M |
2025 Q2
4 quarters
|
|
5
Amazon
AMZN
$2.81T
| $303M | 5.52% |
1,271,687
+212,417
| +20% | +$53.3M |
2023 Q1
13 quarters
|
|
6
PUT
iShares Russell 2000 ETF
IWM
$77.7B
| $276M | 5.02% |
918,200
+543,200
| +145% | +$153M |
2026 Q1
1 quarter
|
|
|
7
Agilent Technologies
A
$48.1B
| $262M | 4.76% |
+1,969,541
| New | +$240M |
2026 Q2
0 quarters
|
|
|
8
Danaher
DHR
$157B
| $218M | 3.97% |
1,145,979
+989,704
| +633% | +$180M |
2025 Q2
4 quarters
|
|
|
9
Meta Platforms (Facebook)
META
$1.94T
| $201M | 3.66% |
356,841
+234,179
| +191% | +$143M |
2025 Q1
5 quarters
|
|
10
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$820B
| $194M | 3.54% |
+260,000
| New | +$189M |
2026 Q2
0 quarters
|
|
|
11
Advanced Micro Devices
AMD
$960B
| $173M | 3.16% |
298,410
-352,382
| -54% | -$144M |
2025 Q4
2 quarters
|
|
12
Teva Pharmaceutical Industries Limited
TEVA
$48.1B
| $172M | 3.13% |
5,081,091
-1,579,129
| -24% | -$52.6M |
2023 Q4
10 quarters
|
|
13
Viatris
VTRS
$20B
| $157M | 2.86% |
9,877,409
+790,165
| +9% | +$12.2M |
2023 Q4
10 quarters
|
|
14
Uber
UBER
$145B
| $129M | 2.36% |
1,793,598
+337,726
| +23% | +$24.8M |
2021 Q2
20 quarters
|
|
|
15
Centene
CNC
$33.6B
| $121M | 2.2% |
1,886,055
-1,327,591
| -41% | -$71M |
2025 Q3
3 quarters
|
|
16
Butterfly Network
BFLY
$2.18B
| $121M | 2.2% |
14,335,055
| – | – |
2021 Q1
21 quarters
|
|
17
Cigna
CI
$74.7B
| $114M | 2.07% |
412,223
-86,618
| -17% | -$24.5M |
2013 Q2
52 quarters
|
|
18
Humana
HUM
$50.5B
| $101M | 1.84% |
254,216
-80,676
| -24% | -$23M |
2026 Q1
1 quarter
|
|
19
Block Inc
XYZ
$45.9B
| $91M | 1.66% |
1,197,046
-167,425
| -12% | -$11.8M |
2025 Q3
3 quarters
|
|
20
Dick's Sporting Goods
DKS
$13.5B
| $91M | 1.66% |
401,067
+102,156
| +34% | +$22.6M |
2025 Q2
4 quarters
|
|
21
Genius Sports
GENI
$1.77B
| $81.8M | 1.49% |
13,495,287
+4,934,399
| +58% | +$25.5M |
2025 Q4
2 quarters
|
|
22
Onto Innovation
ONTO
$12.8B
| $77.9M | 1.42% |
205,791
-93,930
| -31% | -$26.6M |
2025 Q3
3 quarters
|
|
23
Eli Lilly
LLY
$1.05T
| $69.3M | 1.26% |
+57,771
| New | +$59M |
2026 Q2
0 quarters
|
|
24
United Airlines
UAL
$33.2B
| $67.3M | 1.23% |
494,736
-2,124
| -0.4% | -$220K |
2025 Q1
5 quarters
|
|
25
National Vision
EYE
$1.34B
| $59M | 1.07% |
3,101,083
+1,535,166
| +98% | +$31.3M |
2025 Q2
4 quarters
|
|
Similar funds
GCM
VCM
ACM
MC
SCM
NC
EI
AP
Glenview Capital Management's Q2 2026 Portfolio in Review
As of Q2 2026, Glenview Capital Management held 58 positions worth $5.49B, up 38% from $3.98B the previous quarter. Its ten largest holdings account for 61% of the portfolio.
Glenview Capital Management deployed $309M of net new capital in Q2 2026, opening 14 new positions and adding to 15 existing holdings. Its largest new stake was Agilent Technologies: 1,969,541 shares worth $262M.
By sector, the portfolio is most concentrated in Healthcare at 50% of assets, up from 45% a quarter earlier, followed by Industrials and Technology.
On the sell side, the largest reduction was CVS Health, an estimated $301M trimmed.
- Glenview Capital Management's largest Q2 2026 buy was Agilent Technologies: 1,969,541 shares worth $262M.
- Glenview Capital Management added most to Thermo Fisher Scientific in Q2 2026, an estimated $181M increase.
- Glenview Capital Management's biggest Q2 2026 reduction was CVS Health, cutting an estimated $301M.
- Glenview Capital Management fully exited DXC Technology in Q2 2026, selling an estimated $112M.
- Glenview Capital Management's ten largest holdings make up 61% of its $5.49B portfolio in Q2 2026.
- Glenview Capital Management opened 14 new positions and closed 13 in Q2 2026.
- Glenview Capital Management's portfolio value rose 38% quarter-over-quarter to $5.49B.
Based on Glenview Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.